INCANTHERA
DEAD

Serial Number

87070001

Owner

Incanthera Limited

Attorney

Jeffrey A. Smith

Filing Date

Jun 13, 2016

Add to watchlist:

No watchlists yet
View on USPTO

INCANTHERA Trademark

Serial Number: 87070001 • Registration: 5724523

INCANTHERA is a trademark filed by Incanthera Limited on June 13, 2016. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 45 (Legal & Security Services). The application is currently no longer active.

Owner Contact Info

Incanthera Limited

76 King Street
Manchester M24NH , GB

Entity Type: 11

Trademark Details

Filing Date

June 13, 2016

Registration Date

April 16, 2019

Published for Opposition

December 18, 2018

Cancellation Date

October 31, 2025

Goods & Services

Therapeutic pharmaceutical preparations for the treatment of cancer; therapeutic pharmaceutical preparations for the prevention of cancer; anti-cancer therapeutic pharmaceutical preparations; pharmaceutical preparations for cancer therapeutics; therapeutic pharmaceutical compounds for treating cancer

Acquisition and licensing of intellectual property; licensing of technology, namely, computer software, hardware and medical devices, for medical research and cancer treatment purposes; licensing of technology, namely, computer software, hardware and medical devices, for research in the field of cancer treatment; licensing of technology, namely, computer software, hardware and medical devices, for use in the field of medical science

Scientific and technological services and research and design relating thereto, namely, medical research services, pharmaceutical drug development and pharmaceutical research and development; Scientific and technological services and research and design relating thereto, namely, medical and scientific research in the field of cancer treatment and diagnosis; scientific research, namely, scientific research; scientific and industrial research, namely, industrial research in the field of medical science and compiling data for research purposes in the field of medical science and medical consultancy; laboratory research services relating to pharmaceuticals; pharmaceutical product development; consultancy relating to research and development in the fields of pharmaceuticals and therapeutics; scientific and technological services and research and design relating thereto, namely, conducting clinical trials for others; industrial research, namely, compilation of data for research purposes in the field of medical science, research in the field of anti-cancer drug delivery systems; laboratory research services relating to pharmaceuticals; pharmaceutical product development; consultancy relating to research and development in the fields of pharmaceuticals and therapeutics

Filing History

CANCELLED SEC. 8 (6-YR)
Oct 31, 2025 C8..
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Apr 16, 2024 REM1
REGISTERED-PRINCIPAL REGISTER
Apr 16, 2019 R.PR
1(B) BASIS DELETED; PROCEED TO REGISTRATION
Mar 12, 2019 DP1B
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Mar 12, 2019 AITU
NOTICE OF ALLOWANCE CANCELLED
Feb 21, 2019 IUCN
TEAS DELETE 1(B) BASIS RECEIVED
Feb 21, 2019 D1BR
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Feb 12, 2019 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 18, 2018 NPUB
PUBLISHED FOR OPPOSITION
Dec 18, 2018 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 28, 2018 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 9, 2018 CNSA
EXAMINER'S AMENDMENT ENTERED
Nov 9, 2018 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 9, 2018 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 9, 2018 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 9, 2018 CNEA
NOTIFICATION OF FINAL REFUSAL EMAILED
May 9, 2018 GNFN
FINAL REFUSAL E-MAILED
May 9, 2018 GNFR
FINAL REFUSAL WRITTEN
May 9, 2018 CNFR
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Apr 19, 2018 RCCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Oct 13, 2017 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Apr 11, 2017 GNS3
LETTER OF SUSPENSION E-MAILED
Apr 11, 2017 GNSL
SUSPENSION LETTER WRITTEN
Apr 11, 2017 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 24, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 24, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 22, 2017 TROA
NOTIFICATION OF PRIORITY ACTION E-MAILED
Sep 22, 2016 GPRN
PRIORITY ACTION E-MAILED
Sep 22, 2016 GPRA
PRIORITY ACTION WRITTEN
Sep 22, 2016 CPRA
ASSIGNED TO EXAMINER
Sep 21, 2016 DOCK
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Aug 23, 2016 AMPX
ASSIGNED TO LIE
Aug 16, 2016 ALIE
TEAS VOLUNTARY AMENDMENT RECEIVED
Aug 8, 2016 PARI
NOTICE OF DESIGN SEARCH CODE E-MAILED
Jun 22, 2016 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 21, 2016 NWOS
NEW APPLICATION ENTERED
Jun 16, 2016 NWAP
FAX RECEIVED
Jun 13, 2016 FAXX